bpc-157-coa BPC-157 - Certificate of Analysis - Batch 2602180021 BPC-157 — ≥99% Purity, COA

For instance, for sheep in extremely deficient areas, repeat the dose every 2-3 months

Schedule: Daily subcutaneous injections for 48 weeks (extend to 12 weeks if desired)

Medicines containing probenecid or sulfinpyrazone may prolong the excretion of diclofenac The absorption of vitamin B 12 in the gastrointestinal tract is reduced by the administration of the following drugs: aminoglycosides, colchicine, extended release potassium, aminosalicylic acid and its salt, anti-convulsive agent (phenytoin, phenobarbital and primodone), cobalt radiation in the small intestine and by excessive intake of alcohol for more than 2 weeks

Cagrilintide, the second generation (2020s) Novo Nordisk took the Pramlintide concept and applied the same half-life extension strategy that they used with Semaglutide: Kept the proline substitutions (anti-amyloid) Added a C20 fatty diacid via a -Glu linker to a lysine residue, albumin binding Additionally stabilized the N- and C-terminal positions Result: Cagrilintide with a half-life of 6.6 days (vs 50 minutes for Pramlintide)